Childhood anxiety disorders and developmental issues in anxiety

Current Psychiatry Reports

Volumn 5, Issue 4, 2003, Pages 252-265

  Arnold, Paul ^a   Banerjee, S Preeya ^b   Bhandari, Rashmi ^b   Lorch, Elisa ^b   Ivey, Jennifer ^b   Rose, Michelle ^b   Rosenberg, David R ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; IMMUNOGLOBULIN; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PENICILLIN G; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROID HORMONE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULTHOOD; AGE DISTRIBUTION; AGORAPHOBIA; ANXIETY DISORDER; AUTOIMMUNE DISEASE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CHILD; CHILD DEVELOPMENT; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE PREDISPOSITION; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERACTIVITY; LEG DISEASE; MEDICAL RESEARCH; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PANIC; PARENTAL BEHAVIOR; PHYSICAL DISEASE; POSTTRAUMATIC STRESS DISORDER; PSYCHOSOCIAL CARE; RECURRENT INFECTION; RESTLESSNESS; REVIEW; SEDATION; SEPARATION ANXIETY; SIDE EFFECT; SOCIAL ADAPTATION; SOCIAL PHOBIA; SOMNOLENCE; STREPTOCOCCUS INFECTION; XEROSTOMIA; DEVELOPMENTAL DISORDER; METHODOLOGY; PHOBIA; PSYCHOLOGICAL ASPECT;

ANXIETY DISORDERS; ANXIETY, SEPARATION; BENZODIAZEPINES; CHILD; COGNITIVE THERAPY; DEVELOPMENTAL DISABILITIES; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0642305566     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0054-9     Document Type: Review

References (95)

1. Verhulst F: Community and epidemiological aspects of anxiety disorders in children. In Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention. Edited by Silverman W, Treffers P. Cambridge: Cambridge University Press; 2001:273-292.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4, Text Revision. Washington, DC: American Psychiatric Association; 2000.
3. Gullone E: The development of normal fear: a century of research. Clin Psychol Rev 2000, 20:429-451.
4. Freeman J, Garcia A, Leonard H: Anxiety disorders. In Child and Adolescent Psychiatry: A Comprehensive Textbook. Edited by Lewis M. Philadelphia: Lippincott Williams & Wilkins; 2002:821-834.
5. Masi G, Mucci M, Millepiedi S: Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management. CNS Drugs 2001, 15:93-104.
6. Ost L-G, Treffers P: Onset, course and outcome for anxiety disorders in children. In Anxiety Disorders in Children and Adolescents: Research, Assessment and Intervention. Edited by Silverman W, Treffers P. Cambridge: Cambridge University Press; 2001.
7. Silove D, Manicavasagar V, Curtis J, Blaszczynski A: Is early separation anxiety a risk factor for adult panic disorder? A critical review. Compr Psychiatry 1996, 37:167-179.
8. Pine DS, Klein RG, Coplan JD, et al.: Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group. Arch Gen Psychiatry 2000, 57:960-967.
9. Slattery MJ, Klein DF, Mannuzza S, et al.: Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. J Am Acad Child Adolesc Psychiatry 2002, 41947-954.
10. Kendler KS, Myers J, Prescott CA: The etiology of phobias: an evaluation of the stress-diathesis model. Arch Gen Psychiatry 2002, 59:242-248.
11. Birmaher B, Ryan ND, Williamson DE, et al.: Childhood and adolescent depression: a review of the past 10 years: part 1. J Am Acad Child Adolesc Psychiatry 1996, 35:1427-1439.
12. Pine DS, Cohen P, Gurley D, et al.: The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998, 55:56-64.
13. Axelson DA, Birmaher B: Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001, 14:67-78.
14. Schwartz CE, Snidman N, Kagan J: Adolescent social anxiety as an outcome of inhibited temperament in childhood. J Am Acad Child Adolesc Psychiatry 1999, 38:1008-1015.
15. Goodwin RD, Hamilton SP: Early-onset fearful panic attack: a possible prodrome of early-onset severe psychopathology. Compr Psychiatry 2002, 43:22-27.
16. Yule W: Posttraumatic stress disorder in the general population and in children. J Clin Psychiatry 2001, 62(suppl):23-28.
17. Terr L: Children's symptoms in the wake of Challenger: a field study of distant-traumatic events and an outline of related conditions. Am J Psychiatry 1999, 156:1536-1544.
18. Geller D, Biederman J, Jones J, et al.: Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry 1998, 5:260-273.
19. Eichstedt J, Arnold S: Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 2001, 21:137-158.
20. Geller D, Biederman J, Faraone S, et al.: Developmental aspects of obsessive-compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 2001, 189:471-477.
21. Asbahr FR, Negrao AB, Gentil V, et al.: Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998, 155:1122-1124.
22. Swedo S: Immunology of neurodevelopmental disorders: pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry 2001, 7:S24-S25.
23. Murphy M, Pichichero M: Prospective identification and treatment of children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Group A Streptococcal Infection (PANDAS). Arch Pediatr Adolesc Med 2002, 156:356-361.
24. Lougee L, Perlmutter S, Nicolson R, et al.: Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry 2000, 39:1120-1126.
25. Dadds MR, Barrett PM: Practitioner review: psychological management of anxiety disorders in childhood. J Child Psychol Psychiatry 2001, 42:999-1011.
26. Mendlowitz SL, Manassis K, Bradley S, et al.: Cognitive-behavioral group treatments in childhood anxiety disorders: the role of parental involvement. J Am Acad Child Adolesc Psychiatry 1999, 38:1223-1229.
27. Manassis K, Mendlowitz SL, Scapillato D, et al.: Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. J Am Acad Child Adolesc Psychiatry 2002, 41:1423-1430.
28. Hettema JM, Neale MC, Kendler KS: A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001, 158:1568-1578.
29. Cobham VE, Dadds MR, Spence SH: The role of parental anxiety in the treatment of childhood anxiety. J Consult Clin Psychol 1998, 66:893-905.
30. Hudson JL, Kendall PC: Showing you can do it: homework in therapy for children and adolescents with anxiety disorders. J Clin Psychol 2002, 58:525-534.
31. Barrett PM: Treatment of childhood anxiety: developmental aspects. Clin Psychol Rev 2000, 20:479-494.
32. King NJ, Tonge BJ, Heyne D, et al.: Cognitive-behavioral treatment of school-refusing children: a controlled evaluation. J Am Acad Child Adolesc Psychiatry 1998, 37:395-403.
33. Silverman WK, Kurtines WM, Ginsburg GS, et al.: Contingency management, self-control, and education support in the treatment of childhood phobic disorders: a randomized clinical trial. J Consult Clin Psychol 1999, 67:675-687.
34. Leger E, Ladouceur R, Dugas MJ, Freeston MH: Cognitive-behavioral treatment of generalized anxiety disorder among adolescents: a case series. J Am Acad Child Adolesc Psychiatry 2003, 42:327-330.
35. Hayward C, Varady S, Albano AM, et al.: Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:721-726.
36. Beidel DC, Turner SM, Morris TL: Behavioral treatment of childhood social phobia. J Consult Clin Psychol 2000, 68:1072-1080.
37. Spence SH, Donovan C, Brechman-Toussaint M: The treatment of childhood social phobia: the effectiveness of a social skills training-based, cognitive-behavioral intervention, with and without parental involvement. J Child Psychol Psychiatry 2000, 41:713-726.
38. Ollendick T: Cognitive-behavioral treatment of panic disorder with agoraphobia in adolescents: a multiple baseline design analysis. Behav Ther 1995, 26:517-531.
39. Pine DS, Cohen JA: Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol Psychiatry 2002, 51:519-531.
40. March JS, Amaya-Jackson L, Murray MC, Schulte A: Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. J Am Acad Child Adolesc Psychiatry 1998, 37:585-593.
41. March JS, Franklin M, Nelson A, Foa E: Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol 2001, 30:8-18.
42. Benazon NR, Ager J, Rosenberg DR: Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther 2002, 40:529-539.
43. Franklin ME, Kozak MJ, Cashman LA, et al.: Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry 1998, 37:412-419.
44. March JS, Mulle K, Herbel B: Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry 1994, 33:333-341.
45. Piacentini J, Bergman RL, Jacobs C, et al.: Open trial of cognitive behavior therapy for childhood obsessive-compulsive disorder. J Anxiety Disord 2002, 16:207-219.
46. Wever C, Rey JM: Juvenile obsessive-compulsive disorder. Aust N Z J Psychiatry 1997, 31:105-113.
47. Thienemann M, Martin J, Cregger B, et al.: Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2001, 40:1254-1260.
48. Waters TL, Barrett PM, March JS: Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: preliminary findings. Am J Psychother 2001, 55:372-387.
49. Barrett PM, Healy LJ: An examination of the cognitive processes involved in childhood obsessive-compulsive disorder. Behav Res Ther 2003, 41:285-299.
50. Muratori F, Picchi L, Bruni G, et al.: A two-year follow-up of psychodynamic psychotherapy for internalizing disorders in children. J Am Acad Child Adolesc Psychiatry 2003, 42:331-339.
51. Rosenberg D: Selective serotonin reuptake inhibitors. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker; 2002:223-296.
52. Research Unit on Pediatric Psychopharmacology Anxiety Study Group: Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001, 344:1279-1285.
53. Borzo G: Fluvoxamine treats anxiety in children, teens. Clin Psychiatry News 2000, 28:10.
54. Walkup J, Labellarte M, Riddle MA, et al.: Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol 2002, 12:175-188.
55. Walkup JT, Labellarte MJ, Riddle MA, et al.: Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003, 42:13-21.
56. Rynn MA, Siqueland L, Rickels K: Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001, 158:2008-2014.
57. Rynn M, Kunz N, Lamm L, et al.: Venlafaxine XR for treatment of GAD in children and adolescents. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:91.
58. Compton SN, Grant PJ, Chrisman AK, et al.: Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 2001, 40:564-571.
59. Chavira DA, Stein MB: Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. J Child Adolesc Psychopharmacol 2002, 12:47-54.
60. Wagner K, Stein M, Berard R, et al.: Efficacy of paroxetine in childhood and adolescent social anxiety disorder. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:95.
61. Masi G, Toni C, Mucci M, et al.: Paroxetine in children and adolescent outpatients with panic disorder. J Child Adolesc Psychopharmacol 2001, 11:151-157.
62. Cohen JA, Mannarino AP, Rogal S: Treatment practices for childhood posttraumatic stress disorder. Child Abuse Negl 2001, 25:123-135.
63. Seedat S, Stein DJ, Ziervogel C, et al.: Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2002, 12:37-46.
64. March J, Frances A, Carpenter D, et al.: Treatment of obsessive-compulsive disorder: the Expert Consensus Panel for obsessive-compulsive disorder. J Clin Psychiatry 1997, 58(suppl):2-72.
65. Cartwright C, Hollander E: SSRIs in the treatment of obsessive-compulsive disorder. Depress Anxiety 1998, 8(suppl):105-113.
66. Ivey J, Rosenberg DR: Clomipramine use in obsessive-compulsive disorder. Expert Rev Neurotherapeutics 2002, 2:783-790.
67. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al.: Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 2001, 40:222-229.
68. March JS, Biederman J, Wolkow R, et al.: Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 1998, 280:1752-1756.
69. Geller DA, Hoog SL, Heiligenstein JH, et al.: Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001, 40:773-779.
70. Geller D, Wagner K, Emslie G, et al.: Efficacy of paroxetine in pediatric OCD: results of a multicenter study. Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:117.
71. Thomsen PH, Ebbesen C, Persson C: Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 2001, 40:895-902.
72. Greist J, Chouinard G, DuBoff E, et al.: Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995, 52:289-295.
73. Findling RL, Reed MD, Myers C, et al.: Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:952-959.
74. McDougle CJ, Epperson CN, Pelton GH, et al.: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:794-801.
75. Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR: Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 1999, 9:115-123.
76. Crocq M, Leclerq P, Guillon M, Bailey P: Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment. Eur Psychiatry 2002, 17:296-297.
77. McDougle CJ, Goodman WK, Leckman JF, et al.: Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994, 51:302-308.
78. Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS: Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 1998, 8:61-67.
79. Pigott T, Sheay S: Pharmacotherapy of obsessive-compulsive disorder: overview and treatment-refractory strategies. In Obsessive-compulsive Disorder: Contemporary Issues in Treatment. Edited by Goodman W, Rudorfer M, Maser J. Mahwah: Lawrence Erlbaum Associates; 2000:277-302.
80. Rosenberg D, MacMaster F, Keshavan M, et al.: Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000, 39:1096-1103.
81. Rosenberg D: Toward a neuroodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998, 43:623-640.
82. Arnold P, Mundo E, Richter M, et al.: Are NMDA genes linked to early onset obsessive-compulsive disorder? Scientific proceedings of the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco: American Academy of Child and Adolescent Psychiatry; 2002:118.
83. Rosenberg D, Hanna G: Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biol Psychiatry 2000, 48:1210-1222.
84. Garvey M, Perlmutter S, Allen A, et al.: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45:1564-1571.
85. Arnold P, Richter M: Is obsessive-compulsive disorder an autoimmune disease? Can J Psychiatry 2001, 165:1353-1358.
86. Perlmutter S, Leitman S, Garvey M, et al.: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999, 354:1153-1158.
87. Nicolson R, Swedo S, Lenane M, et al.: An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without post-streptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000, 39:1313-1315.
88. Cook EH, Wagner KD, March JS, et al.: Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2001, 40:1175-1181.
89. Wagner K, Cook E, Chugn H, et al.: Remission status after long-term sertraline treatment of pediatric OCD. J Child Adolesc Psychopharmacol 2003, in press.
90. Gallagher D, Gardiner C, Carpenter D: Interim results: long-term safety of paroxetine in pediatric patients. New Research Program and Abstract presented at the 155th Annual Meeting of the American Psychiatric Association. Philadelphia, PA; May 10-14, 2002.
91. Weintrob N, Cohen D, Klipper-Aurbach Y, et al.: Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002, 156:696-701.
92. Rosenberg D: Anxiolytics. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker; 2002:489-541.
93. Rosenberg D: Tricyclic antidepressants. In Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Edited by Rosenberg D, Davanzo P, Gershon S. New York: Marcel Dekker, 2002:169-222.
94. Bernstein GA, Borchardt CM, Perwien AR, et al.: Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 2000, 39:276-283.
95. Layne A, Bernstein G, Egan F, Kushner M: Predictors of treatment response in anxious-depressed adolescents with school refusal. J Am Acad Child Adolesc Psychiatry 2003, 42:319-326.